Calcium channel blockers mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Calcium Channel Blockers: Mechanism of Action Overview
Calcium channel blockers (CCBs) are a group of drugs that prevent calcium ions (Ca2+) from entering certain cells, especially those in the heart and blood vessels. This action has significant effects on cardiovascular function and is the basis for their use in treating conditions like hypertension, angina, and some arrhythmias 1358+2 MORE.
Inhibition of Calcium Entry in Excitable Cells
CCBs work by blocking calcium-selective channels in the plasma membrane of excitable cells, such as cardiac muscle cells and vascular smooth muscle cells. By inhibiting the entry of Ca2+ into these cells, CCBs reduce the ability of calcium to act as an intracellular messenger, which is essential for muscle contraction and other cellular processes 1389+1 MORE.
Effects on the Cardiovascular System
Vascular Smooth Muscle Relaxation
By blocking calcium entry, CCBs cause relaxation of vascular smooth muscle, leading to vasodilation. This effect lowers systemic blood pressure and reduces the workload on the heart, making CCBs effective antihypertensive agents 1589+1 MORE.
Negative Inotropic and Chronotropic Effects
In the heart, CCBs decrease the force of contraction (negative inotropic effect) and can slow the heart rate (negative chronotropic effect). This is particularly important in the atria and ventricles, where calcium is crucial for muscle contraction, and in the sinoatrial (SA) and atrioventricular (AV) nodes, where calcium channels are responsible for the upstroke of the action potential and impulse conduction 1389+1 MORE.
Selectivity Among Calcium Channel Blockers
Different CCBs have varying selectivity for vascular smooth muscle versus cardiac muscle. For example, nifedipine is more potent in vascular smooth muscle, while verapamil and diltiazem are approximately equally effective in both the heart and blood vessels. This selectivity can be used to tailor therapy for specific cardiovascular conditions 1589+1 MORE.
Molecular and Structural Mechanisms
CCBs interact with specific binding sites on L-type voltage-operated calcium channels, often by first dissolving in the cell membrane and then binding to hydrophobic regions of the channel proteins. The structural differences among CCBs (such as dihydropyridines, phenylalkylamines, and benzothiazepines) influence their binding sites and blocking potency 1568.
Additional Mechanisms and Effects
Some CCBs may also have effects beyond simple calcium channel blockade, such as suppressing cell proliferation and chemotaxis involved in atherosclerosis, or modulating immune cell function through effects on other types of calcium channels like CRAC channels 47.
Conclusion
Calcium channel blockers act primarily by inhibiting the entry of calcium ions into excitable cells, especially in the heart and blood vessels. This leads to vasodilation, reduced cardiac contractility, and slowed heart rate, making them valuable in treating hypertension, angina, and certain arrhythmias. Differences in tissue selectivity and molecular interactions among various CCBs allow for tailored therapeutic use in different clinical scenarios 1356+3 MORE.
Sources and full results
Most relevant research papers on this topic